New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Journal of Molecular Structure

• Publication date

  2024-01-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.molstruc.2023.137465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies

  2023cited by this paper
• In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2

  2023cited by this paper
• Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity

  2022cited by this paper
• Novel synthesis of multicomponent porous nano-hybrid composite, theoretical investigation using DFT and dye adsorption applications: disposing of waste with waste

  2022cited by this paper
• (E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies

  2022cited by this paper
• Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies

  2022cited by this paper
• Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2

  2022cited by this paper
• Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies

  2022cited by this paper
• Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors

  2022cited by this paper
• Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

  2022cited by this paper
• In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative

  2022cited by this paper
• Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation

  2022cited by this paper
• Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies

  2022cited by this paper
• Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway

  2022cited by this paper
• New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies

  2022cited by this paper
• New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.

  2021cited by this paper
• ProLIF: a library to encode molecular interactions as fingerprints

  2021cited by this paper
• 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies

  2021cited by this paper
• New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies

  2021cited by this paper
• New quinoxaline-2(1H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations

  2021cited by this paper
• Cadmium oxide nanoparticles/graphene composite: synthesis, theoretical insights into reactivity and adsorption study

  2021cited by this paper
• gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS.

  2021cited by this paper
• Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study

  2021cited by this paper
• Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents.

  2021cited by this paper
• What is the current value of MM/PBSA and MM/GBSA methods in drug discovery?

  2021cited by this paper
• Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold.

  2020cited by this paper
• Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer’s Agents Targeting BACE1 and PPARγ

  2020cited by this paper
• Open access in silico tools to predict the ADMET profiling of drug candidates

  2020cited by this paper
• Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective

  2019cited by this paper
• ADMET modeling approaches in drug discovery.

  2019cited by this paper
• TTClust: A Versatile Molecular Simulation Trajectory Clustering Program with Graphical Summaries

  2018cited by this paper
• Bax, Bak and beyond — mitochondrial performance in apoptosis

  2018cited by this paper
• VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)

  2017cited by this paper
• Flow cytometry: basic principles and applications

  2017cited by this paper
• Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents

  2015cited by this paper
• GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

  2015cited by this paper
• Synthesis, Biological Evaluation and 2D-QSAR Study of Halophenyl Bis-Hydrazones as Antimicrobial and Antitubercular Agents

  2015cited by this paper
• An analysis of the attrition of drug candidates from four major pharmaceutical companies

  2015cited by this paper
• CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field

  2015cited by this paper
• PLIP: fully automated protein–ligand interaction profiler

  2015cited by this paper
• CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues.

  2014cited by this paper
• Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment

  2014cited by this paper
• Regulation of Angiogenesis in Human Cancer via Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2)

  2012cited by this paper
• Oxadiazoles in medicinal chemistry.

  2012cited by this paper
• Toward in silico structure-based ADMET prediction in drug discovery.

  2012cited by this paper
• Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

  2011cited by this paper
• Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease.

  2011cited by this paper
• Flow cytometry-based apoptosis detection.

  2009cited by this paper
• Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case.

  2009cited by this paper
• High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.

  2008cited by this paper
• Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.

  2007cited by this paper
• Free energy landscape of a biomolecule in dihedral principal component space: Sampling convergence and correspondence between structures and minima

  2007cited by this paper
• Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.

  2006cited by this paper
• IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.

  2005cited by this paper
• Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

  2002cited by this paper
• Similarities between principal components of protein dynamics and random diffusion

  2000cited by this paper
• Bcl-2 family proteins

  1998cited by this paper
• Structure-based drug design: computational advances.

  1997cited by this paper
• SYNTHESIS AND EFFECT OF GAMMA RADIATION ON SOME SULFUR CONTAINING 3-SUBSTITUTED-4-OXO-2,4,5,6,7,8-HEXAHYDROBENZO [b]THIENO-[2,3-d]PYRIMIDINES OF BIOLOGICAL INTEREST

  1995cited by this paper
• A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.

  1994cited by this paper
• Essential dynamics of proteins

  1993cited by this paper
• Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

  1988cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Palladium catalyst synthesis, computational chemical study and molecular docking of a new series of (aryl)-2-(trifluoromethyl) tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one derivatives

  2026cites this paper
• From pain relief to proliferation arrest: Synthesis and biological evaluation of novel diclofenac-tethered Schiff bases as VEGFR-2 inhibitors and apoptosis inducers, guided by in silico molecular docking and ADME profiling.

  2026cites this paper
• A new antitumor platinum(II) complex containing metformin drug: synthesis, characterization, cellular responses, and theoretical study

  2025cites this paper
• Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitors.

  2025cites this paper
• New Thiadiazole-Benzenesulfonamide Hybrids as Dual B-Raf/VEGFR-2 Inhibitors With Promising Anti-Hepatic Cancer Activity.

  2025cites this paper
• Discovery of new thieno[2,3-d]pyrimidine-based dual VEGFR-2 and EGFR inhibitors for enhanced therapeutic efficacy in breast cancer

  2025cites this paper
• Anti-breast cancer potential of thieno-pyrimidine derivatives as VEGFR-2 inhibitors.

  2025cites this paper
• New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations

  2025cites this paper
• One‐Pot Three‐Component Construction of 2,4‐Diarylbenzo[4,5] thieno[3,2‐d] pyrimidines Using Elemental Sulfur as a Sulfur Source

  2024cites this paper
• Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2

  2024cites this paper
• Novel pyrazole-4-carboxamides containing a piperazine moiety: Synthesis, crystal structure, antifungal activity, molecular docking, DFT and ESP calculations

  year unknowncites this paper